These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6239415)

  • 1. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal.
    Flechner SM; Kerman RH; Van Buren CT; Epps L; Kahan BD
    Transplantation; 1984 Dec; 38(6):685-91. PubMed ID: 6239415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
    Flechner SM; Kerman RH; Van Buren C; Kahan BD
    Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
    Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1987 Feb; 43(2):205-10. PubMed ID: 2949404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston.
    Kahan BD; Kerman RH; Wideman CA; Flechner SM; Jarowenko M; Van Buren CT
    Am J Kidney Dis; 1985 Jun; 5(6):288-95. PubMed ID: 3925760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry M; Ferguson RM
    Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of steroid immunosuppression in renal transplant recipients.
    Stratta RJ; Armbrust MJ; Oh CS; Pirsch JD; Kalayoglu M; Sollinger HW; Belzer FO
    Transplantation; 1988 Feb; 45(2):323-8. PubMed ID: 3278423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.
    Reinsmoen NL; Kaufman D; Matas A; Sutherland DE; Najarian JS; Bach FH
    Transplantation; 1990 Nov; 50(5):783-90. PubMed ID: 2146784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplantation; 1987 Jan; 43(1):65-70. PubMed ID: 3541326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA; Mayes JT; Moritz CE; Hricik DE
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
    Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
    Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cyclosporine influence the results of cadaver retransplantation?
    Flechner SM; Lorber MI; Kerman RH; Van Buren CT; Wideman C; Kahan BD
    Hum Immunol; 1985 Nov; 14(3):305-13. PubMed ID: 3902748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.